Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
TCBP TC BioPharm
5.120-0.100-1.92%
Close
01/31 16:00 ET
5.1200.0000.00%
Pre Mkt Price 02/01 04:05 ET
High
5.500
Open
5.120
Turnover
2.74M
Low
4.800
Pre Close
5.220
Volume
531.13K
Pre-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
TC BioPharm Announces Hiring of Chief Clinical Officer Bree Harlin to Lead Global Clinical Division
Will oversee expansion of U.S. FDA Clinical TrialsEDINBURGH, Scotland, Jan. 30, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ:TCBP) (NASDAQ:TCBPW), a clinical
TC Biopharm Names Bree Harlin as Chief Clinical Officer
IOVA, NVVE, and APLT Are Among Pre Market Gainers
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersRedhill Biopharma (NASDAQ:RDHL) stock rose 35.0% to $0.25 during Friday's pre-market session. The market value of their outstanding shares is at $22.6 million. Akanda (NASDAQ:AKAN) stock moved
Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MicroAlgo Inc. (NASDAQ:MLGO) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.Akanda Corp. (NASDAQ:AKAN) gained 52% to $0.2980.B
Aptorum, Nemaura Top Healthcare Gainers; Panbela, Aridis Lead Losers' Pack
Nasdaq Surges 100 Points; Tesla Beats Q4 Views
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 33,824.53 while the NASDAQ rose
HC Wainwright Starts TC Biopharm (Holdings) at Buy With $9 Price Target
08:31 AM EST, 01/26/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
NIO, LI and BILI Are Among Pre Market Gainers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersMinerva Surgical (NASDAQ:UTRS) stock moved upwards by 82.4% to $0.69 during Thursday's pre-market session. The company's market cap stands at $20.8 million. TC BioPharm (Holdings) (NASDAQ:TCBP)
Company Overview
More
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
CEO： Mr. Bryan Kobel
Market： NASDAQ
Listing Date： 02/11/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet